Protective effect of Salvia miltiorrhiza aqueous extract on myocardium oxidative injury in ischemic-reperfusion rats

Gene

Volumn 546, Issue 1, 2014, Pages 97-103

  Ge, Guanghao ^a   Zhang, Qiong ^a   Ma, Jiangwei ^a   Qiao, Zengyong ^a   Huang, Jianhua ^a   Cheng, Wenbo ^a   Wang, Hongwei ^a  

^a Fengxian Branch of Shanghai 6th People's Hospital   (China)

Author keywords

Antioxidant; JAK2 STAT3 signaling pathway; Myocardium ischemia reperfusion; Salvia miltiorrhiza aqueous extract

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CREATINE KINASE MB; INTERLEUKIN 6; JANUS KINASE 2; LACTATE DEHYDROGENASE; SALVIA MILTIORRHIZA EXTRACT; STAT3 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ELECTROCARDIOGRAPHY; ENZYME ACTIVITY; HEART ARRHYTHMIA; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SALVIA MILTIORRHIZA; ST SEGMENT ELEVATION; UPREGULATION;

RATTUS; SALVIA MILTIORRHIZA;

ANTIOXIDANT; JAK2/STAT3 SIGNALING PATHWAY; MYOCARDIUM ISCHEMIA REPERFUSION; SALVIA MILTIORRHIZA AQUEOUS EXTRACT;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CARDIOTONIC AGENTS; DRUGS, CHINESE HERBAL; ENZYMES; INTERLEUKIN-6; JANUS KINASE 2; L-LACTATE DEHYDROGENASE; MALE; MALONDIALDEHYDE; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; SALVIA MILTIORRHIZA; STAT3 TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84901855046     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2014.05.021     Document Type: Article

References (63)

1. Barry S.P., Townsend P.A., McCormick J., Knight R.A., Scarabelli T.M., Latchman D.S., et al. STAT3 deletion sensitizes cells to oxidative stress. Biochemical and Biophysical Research Communications 2009, 385:324-329.
2. Barth A.S., Merk S., Arnoldi E., Zwermann L., Kloos P., Gebauer M., Steinmeyer K., Bleich M., Kääb S., Pfeufer A., Uberfuhr P., Dugas M., Steinbeck G., Nabauer M. Functional profiling of human atrial and ventricular gene expression. Pflügers Archiv 2005, 450:201-208.
3. Barth A.S., Aiba T., Halperin V., DiSilvestre D., Chakir K., Colantuoni C., Tunin R.S., Dimaano V.L., Yu W., Abraham T.P., Kass D.A., Tomaselli G.F. Cardiac resynchronization therapy corrects dyssynchrony-induced regional gene expression changes on a genomic level. Circulation. Cardiovascular Genetics 2009, 2:371-378.
4. Blaustein M.P. Endogenous ouabain: role in the pathogenesis of hypertension. Kidney International 1996, 49:1748-1753.
5. Boengler K., Buechert A., Heinen Y., Roeskes C., Hilfiker-Kleiner D., Heusch G., et al. Cardioprotection by ischemic postconditioning is lost in aged and STAT3-deficient mice. Circulation Research 2008, 102:131-135.
6. Boengler K., Hilfiker-Kleiner D., Drexler H., Heusch G., Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacology & Therapeutics 2008, 120:172-185.
7. Bolli R., Stein A.B., Guo Y.R., Wang O.L., Rokosh G., Dawn B., et al. A murine model of inducible, cardiac-specific deletion of STAT3: its use to determine the role of STAT3 in the upregulation of cardioprotective proteins by ischemic preconditioning. Journal of Molecular and Cellular Cardiology 2011, 50:589-597.
8. Bozlu M., Eskandari G., Cayan S., et al. The effect of poly (adenosine diphosphate-ribose) polymerase inhibitors on biochemical changes in testicular ischemia-reperfusion injury. The Journal of Urology 2003, 169:1870.
9. Braunersreuther V., Mach F., Montecucco F. Reactive oxygen-induced cardiac intracellular pathways during ischemia and reperfusion. Current Signal Transduction Therapy 2012, 7:89-95.
10. Buege A.J., Aust S.T. Microsomal lipid peroxidation. Methods in Enzymology 1978, 52:302-310.
11. Cain B.S., Harken A.H., Meldrum D.R., et al. Therapeutic strategies to reduce TNF-alpha mediated cardiac contractile depression following ischemia and reperfusion. Journal of Molecular and Cellular Cardiology 1999, 31:931-947.
12. Cain B.S., Meldrum D.R., Meng X., et al. P38 MAPK inhibition decreases TNF-α production and enhances postischemic human myocardial function. The Journal of Surgical Research 1999, 83:7-12.
13. Carlberg I., Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. The Journal of Biological Chemistry 1975, 250:5475-5480.
14. 2+-ATPase activity. Analytical Biochemistry 1986, 157:375-380.
15. Chan K., Chui S.H., Wong D.Y.L., Ha W.Y., Chan C.L., Wong R.N.S. Protective effects of Danshensu from the aqueous extract of Salvia miltiorrhiza (Danshen) against thomocysteine-induced endothelial dysfunction. Life Sciences 2004, 75:3157-3171.
16. Chandrasekar B., Colston J.T., Freeman G.L. Induction of proinflammatory cytokine and antioxidant enzyme gene expression following brief myocardial ischemia. Clinical and Experimental Immunology 1997, 108:346-351.
17. Chen H., Yuan J.P., Chen F., Zhang Y.L., Song J.Y. Tanshinone production in Ti-transformed Salvia miltiorrhiza cell suspension cultures. Journal of Biotechnology 1997, 58(3):147-156.
18. 2+ and ATP. Neurochemistry International 2007, 50:148-158.
19. Chugh S.S., Whitesel S., Turner M., Roberts C.T., Nagalla S.R. Genetic basis for chamber-specific ventricular phenotypes in the rat infarct model. Cardiovascular Research 2003, 57:477-485.
20. Cutler A., Brombacher F. Cytokine therapy. Annals of the New York Academy of Sciences 2005, 1056:16-29.
21. Dietl M., Pohle R., Weingartner M., Polgar R., Grassel E., Schwab S., Kolominsky-Rabas P. Stroke etiology and long-term need of care in ischemic stroke patients. Fortschritte der Neurologie-Psychiatrie 2009, 77(12):714-719.
22. Ferrari R., Guardigli G., Mele D., Percoco G.F., Ceconi C., Curello S. Oxidative stress during myocardial ischaemia and heart failure. Current Pharmaceutical Design 2004, 10:1699-1711.
23. Fuglesteg B.N., Suleman N., Tiron C., Kanhema T., Lacerda L., Andreasen T.V., Sack M.N., Jonassen A.K., Mjøs O.D., Opie L.H., Lecour S. Signal transducer and activator of transcription 3 is involved in the cardioprotective signalling pathway activated by insulin therapy at reperfusion. Basic Research in Cardiology 2008, 103:444-453.
24. Fukuzawa K., Tokumura A. Glutathione peroxidase activity in tissues of vitamin E-deficient mice. Journal of Nutritional Science and Vitaminology 1976, 22:405-407.
25. Gaborit N., Le Bouter S., Szuts V., Varro A., Escande D., Nattel S., Demolombe S. Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart. The Journal of Physiology 2007, 582:675-693.
26. Groeneveld A.B., van Beek J.H., Alders D.J. Assessing heterogeneous distribution of blood flow and metabolism in the heart. Basic Research in Cardiology 2001, 96:575-581.
27. Gurevitch J., Frolkis I., Yuhas Y., et al. Tumor necrosis factor alpha is released from isolated heart undergoing ischemia and reperfusion. Journal of the American College of Cardiology 1996, 28:247-252.
28. Gurevitch J., Frolkis I., Yuhas Y., et al. Anti-tumor necrosis factor-alpha improves myocardial recovery after ischemic and reperfusion. Journal of the American College of Cardiology 1997, 30:1554-1561.
29. Heusch G., Musiolik J., Gedik N., Skyschally A. Mitochondrial STAT3 activation and cardioprotection by ischemic postconditioning in pigs with regional myocardial ischemia/reperfusion. Circulation Research 2011, 109:1302-1308.
30. Heusch G., Musiolik J., Kottenberg E., Peters J., Jakob H., Thielmann M. STAT5 activation and cardioprotection by remote ischemic preconditioning in humans: short communication. Circulation Research 2012, 110:111-115.
31. Hilfiker-Kleiner D., Hilfiker A., Fuchs M., Kaminski K., Schaefer A., Schieffer B., et al. Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circulation Research 2004, 95:187-195.
32. Huang C., Tsai H., Pen R., Hsieh Y.H., Chuang W., Hsu G., Huang W., Chen W. Agaricus blazei Murill ameliorates myocardial ischemia-reperfusion injury. Acta Cardiologica Sinica 2010, 26:235-241.
33. Ishikawa K., Hashimoto H., Mitani S., Toki Y., Okumura K., Ito T. Enalapril improves heart failure induced by monocrotaline without reducing pulmonary hypertension in rats: roles of preserved myocardial creatine kinase and lactate dehydrogenase isoenzymes. International Journal of Cardiology 1995, 47:225-233.
34. Jacoby J.J., Kalinowski A., Liu M.G., Zhang S.S., Gao Q., Chai G.X., et al. Cardiomyocyte-restricted knockout of STAT3 results in higher sensitivity to inflammation, cardiac fibrosis, and heart failure with advanced age. Proceedings of the National Academy of Sciences of the United States of America 2003, 100:12929-12934.
35. Kaminski K.A., Bonda T.A., Korecki J., Musial W.J. Oxidative stress and neutrophil activation-the two keystones of ischemia/reperfusion injury. International Journal of Cardiology 2002, 86:41-59.
36. Kelly R.F., Lamont K.T., Somers S., Hacking D., Lacerda L., Thomas P., Opie L.H., Lecour S. Ethanolamine is a novel STAT-3 dependent cardioprotective agent. Basic Research in Cardiology 2010, 105:763-770.
37. LaFramboise W.A., Bombach K.L., Dhir R.J., Muha N., Cullen R.F., Pogozelski A.R., Turk D., George J.D., Guthrie R.D., Magovern J.A. Molecular dynamics of the compensatory response to myocardial infarct. Journal of Molecular and Cellular Cardiology 2005, 38:103-117.
38. Liu G.T., Zhang T.M., Wang B.E., Wang Y.W. Protective action of seven natural phenolic compounds against peroxidative damage to biomembranes. Biochemical Pharmacology 1992, 43(2):147-152.
39. Lu P.-P., Liu J.-T., Liu N., Guo F., Ji Y.-Y., Pang X.-M. Pro-inflammatory effect of fibrinogen and FDP on vascular smooth muscle cells by IL-6, TNF-α and iNOS. Life Sciences 2011, 88:839-845.
40. Marklund S., Marklund G. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. European Journal of Biochemistry 1974, 47:469-474.
41. Maxwell S.R.J., Lip G.Y.H. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. International Journal of Cardiology 1997, 58:95-117.
42. Meldrum D.R., Cain B.S., Cleveland J.C., et al. Adenosine decreases post-ischemic myocardial TNF-α: anti-inflammatory implications for preconditioning and transplantation. Immunology 1997, 92:472-477.
43. Mirotsou M., Watanabe C.M.H., Schultz P.G., Pratt R.E., Dzau V.J. Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach. Physiological Genomics 2003, 15:115-126.
44. Moreland L.W., Curtis J.R. Systemic nonarticular manifestations of rheumatoid arthritis: focus on inflammatory mechanisms. Seminars in Arthritis and Rheumatism 2009, 39:132-143.
45. Muehling O.M., Jerosch-Herold M., Panse P., Zenovich A., Wilson R.F., Wilson B.V., Wilke N. Regional heterogeneity of myocardial perfusion in healthy human myocardium: assessment with magnetic resonance perfusion imaging. Journal of Cardiovascular Magnetic Resonance 2004, 6:499-507.
46. Näbauer M., Beuckelmann D.J., überfuhr P., Steinbeck G. Regional differences in current density and rate-dependent properties of the transient outward current in subepicardial and subendocardial myocytes of human left ventricle. Circulation 1996, 93:168-177.
47. Noyola-Martínez N., Díaz L., Avila E., Halhali A., Larrea F., Barrera D. Calcitriol downregulates TNF-α and IL-6 expression in cultured placental cells from preeclamptic women. Cytokine 2013, 61:245-250.
48. Palmer J.S., Cromie W.J., Lee R.C. Surfactant administration reduces testicular ischemia-reperfusion injury. The Journal of Urology 1998, 159:2136.
49. Park J.L., Lucchesi B.R. Mechanisms of myocardial reperfusion injury. The Annals of Thoracic Surgery 1998, 68:1905-1912.
50. Qian Y.W., Clusin W.T., Lin S.F., Han J., Sung R.J. Spatial heterogeneity of calcium transient alternans during the early phase of myocardial ischemia in the blood-perfused rabbit heart. Circulation 2001, 104:2082-2087.
51. Roy B., Giri B.R., Chetia M., Swargiary A. Ultrastructural and biochemical alterations in rats exposed to crude extract of Carex baccans and Potentilla fulgens. Microscopy and Microanalysis 2012, 18:1067-1076.
52. Savas C., Dindar H., Aras T., Yucesan S. Pentoxifylline improves blood flow to both testes in testicular torsion. International Urology and Nephrology 2002, 33:81.
53. Sharma M., Gupta Y.K. Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sciences 2002, 7:2489-2498.
54. Sinha A.K. Colorimetric assay of catalase. Analytical Biochemistry 1972, 47:389-394.
55. Stanley W.C., Recchia F.A., Lopaschuk G.D. Myocardial substrate metabolism in the normal and failing heart. Physiological Reviews 2005, 85:1093-1129.
56. Stanton L.W., Garrard L.J., Damm D., Garrick B.L., Lam A., Kapoun A.M., Zheng Q., Protter A.A., Schreiner G.F., White R.T. Altered patterns of gene expression in response to myocardial infarction. Circulation Research 2000, 86:939-945.
57. Strom M., Wan X., Poelzing S., Ficker E., Rosenbaum D.S. Gap junction heterogeneity as mechanism for electrophysiologically distinct properties across the ventricular wall. American Journal of Physiology. Heart and Circulatory Physiology 2010, 298:H787-H794.
58. Torres C., Martinez Jarreta B., Alegret R., Hernandez del Rincón J.P., Falcon M., Gómez Zapata M., Pérez-Cárceles M.D., Osuna E., Luna A. Analysis of ionic ratios in the interventricular wall and their relation with cardiac damage ace seen in an anatomo pathological and cardiac biomarkers. Legal Medicine 2009, 11:S360-S362.
59. +)-stimulated ATPase and acetylcholinesterase activities of dog brain synaptosomal plasma membranes. The Biochemical Journal 1984, 22:301-307.
60. Wei G., Guan Y., Yin Y., Duan J.L., Zhou D., Zhu Y.R., Quan W., Xi M.M., Wen A.D. Anti-inflammatory effect of protocatechuic aldehyde on myocardial ischemia/reperfusion injury in vivo and in vitro. Inflammation 2013, 36:592-602.
61. Yang J., Jiang H., Yang J., Ding J.-W., Chen L.-H., Li S., Zhang X.-D. Valsartan preconditioning protects against myocardial ischemia-reperfusion injury through TLR4/NF-κB signaling pathway. Molecular and Cellular Biochemistry 2009, 330:39-46.
62. Zhang N.N., Andresen B.T., Zhang C.H. Inflammation and reactive oxygen species in cardiovascular disease. World Journal of Cardiology 2010, 2:408-410.
63. Zupko I., Hohmann J., Redei D., Falkay G., Janicsak G., Mathe I. Antioxidant activity of leaves of Salvia species in enzyme-dependent and enzyme-independent systems of lipid peroxidation and their phenolic constituents. Planta Medica 2001, 67(4):366-368.